Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias
- 1 February 1987
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (4) , 307-312
- https://doi.org/10.1016/0002-9149(87)90804-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxinAmerican Heart Journal, 1984
- Beta-adrenoceptor blockade: Electrophysiology and antiarrhythmic mechanismsAmerican Heart Journal, 1984
- Beta-adrenergic blockade by nadolol in control of ventricular tachyarrhythmiasAmerican Heart Journal, 1984
- Acute Electrophysiologic Effects of NadololThe Journal of Clinical Pharmacology, 1983
- Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: Technique, application, and efficacy in severely symptomatic preexcitation patientsAmerican Heart Journal, 1982
- Serial electrophysiologic testing of multiple drugs in patients with atrioventricular nodal reentrant paroxysmal tachycardia.Circulation, 1980
- Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: A new long-acting beta-adrenoceptor blocking drugAmerican Heart Journal, 1980
- Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardiaPublished by Elsevier ,1978
- Electrophysiological studies with multiple drugs in patients with atrioventricular re-entrant tachycardias utilizing an extranodal pathway.Circulation, 1977
- The electrophysiology of propranolol in manAmerican Heart Journal, 1974